Search for: "Sanofi-Aventis US Inc" Results 21 - 40 of 160
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2017, 7:45 am by Ben Vernia
On August 17, the Department of Justice announced that the pharmaceutical company Mylan and its subsidiary had agreed to pay $465 million to the federal and state governments to settle allegations, originally brought by the company’s competitor, Sanofi-Aventis US LLC, that it had defrauded the Medicaid program by falsely declaring its epinephrine syringe, the Epi-Pen, to be a generic device. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
18 Aug 2017, 2:15 pm by Michael Sullivan
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm by Michael Sullivan
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm by Finch McCranie, LLP
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
10 Oct 2016, 2:59 pm by Michael Grossman
Because permanent alopecia should have been announced by Sanofi-Aventis since day one, its absence from the label constituted grounds for action. [read post]
21 Jun 2016, 4:00 am by Paula Bremner
à Is it only a substantive requirement when the invention is a new use, meaning one cannot obtain the invention unless one obtains the new use? [read post]
23 Jun 2015, 2:20 pm
Sanofi-Aventis, U.S., Inc., 2015 WL 3648911 (D.N.J. [read post]
14 May 2015, 4:00 am by Paula Bremner
The Court construed Sanofi’s selection patent and found there was no “promise for use in humans”. [read post]
26 Apr 2015, 4:30 am by Barry Sookman
Music and movie firms back website-blocking in Singapore http://t.co/VyYvVZsIN0 -> Goebbels' estate sues Random House for diary royalties http://t.co/1PDCxZpeuA -> Companies' 'fears are real' with Chinese cyber law http://t.co/4DwKwMLVEx -> European privacy watchdogs join forces to probe Facebook – Oneindia http://t.co/e6M4Q2OEcC -> Computer and Internet Law Weekly Updates for 2015-04-18: blogged: Computer and Internet Law Weekly Updates for…… [read post]
26 Jul 2014, 9:14 pm by Mark Summerfield
  Methods of medical treatment came under scrutiny of the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories, Inc and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (see High Court Rules Methods of Medical Treatment Patent-Eligible). [read post]
18 Jul 2014, 11:55 am
  Gasguzzlers ‘R Us didn’t get its federal bailout and goes bankrupt. [read post]
22 Apr 2014, 7:41 am
United Parcel Serv., Inc., 665 F.3d 68, 73 (3d Cir. 2012).Sanofi-Aventis Deutschland GMBH at *12.Jury InstructionsYou may make an adverse inference in this case against Glenmark. [read post]
19 Apr 2014, 8:50 am by Lawrence B. Ebert
Rev. 629 (2009) :Teva recruited a predecessor of Sanofi-Aventis to help sell its multiple sclerosis drug Copaxone. [read post]